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Abstract
Background: For decades, symptoms of anxiety and depression have been included among psychological factors
associated with development of hypertension. Although this has been questioned in recent studies, most findings
have been based on a single assessment of mental distress at baseline. We examined these associations using
repeated assessments of anxiety, depression and blood pressure.
Methods: Data on 17,410 men and women aged 20 to 67 participating in the Nord-Trøndelag Health Study
(HUNT) in Norway in 1984-86 were re-examined 11 and 22 years later. The main outcome was change in mean
blood pressure (mm Hg) during follow-up.
Results: We found that a high symptom level score (≥80
th percentile) of combined anxiety and depression at
baseline, as compared to a lower symptom level, was associated with lower mean systolic (-0.67 mm Hg, p =
0.044) and diastolic (-0.25 mm Hg, p = 0.201) blood pressure at year 22. A high symptom level present at all three
examinations was associated with a stronger decrease in mean systolic (-1.59 mm Hg, p = 0.004) and diastolic
(-0.78 mm Hg, p = 0.019) blood pressure and with a 20% (p = 0.001) lower risk of developing hypertension (BP
≥140/90 mm Hg) at year 22. The associations were only slightly attenuated in multivariate analyses, with no
evidence of a mediating effect of alteration in heart rate.
Conclusions: This study do not support previous hypothesis that emotional stress may be a cause of hypertension.
Our findings indicate that symptoms of anxiety and depression are associated with decrease in blood pressure,
particularly when a high symptom level can be detected over decades.
Background
The origin of the hypothesis that emotional stress might
be a cause of hypertension goes back to 1919 when
Moschcowitz described features of a stressed personality
type in hypertensive patients [1]. The hypothesis was
later moderately supported in several studies, with the
strongest support for anger and for symptoms of anxiety
and depression leading to hypertension; however, the
psychometric properties of the applied scales are criti-
cized [2]. In recent years, population studies have not
consistently reproduced previous hypothesis and results.
On the contrary, depression and anxiety, the two major
psychiatric disorders, were in several studies associated
with lower blood pressure [3-10]. This was also the case
in the largest general population-based study to date
where we found that symptoms of anxiety and depres-
sion predicted lower blood pressure 11 years later [11].
In contrast, a recent study on a cohort of civil servants
using repeated measures of depressive symptoms and
blood pressure over 24 years suggested that the risk of
hypertension increased with repeated depressive epi-
sodes [12]. Four other prospective studies with non sig-
nificant or contradictory findings were hard to interpret
due the use of self-reported hypertension [13-15], posi-
tive findings in middle-aged but not in elderly indivi-
duals [13], or a short period of follow-up [16].
Overall, previous studies in this area differ in their
findings. With a few exceptions [12,17], however, they
have based their analyses upon a single assessment of
mental distress at baseline. Therefore, in the present
* Correspondence: bjorn.hildrum@hnt.no
1Department of Psychiatry, Namsos Hospital, Nord-Trøndelag Health Trust,
Namsos, Norway
Full list of author information is available at the end of the article
Hildrum et al. BMC Public Health 2011, 11:601
http://www.biomedcentral.com/1471-2458/11/601
© 2011 Hildrum et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.study we wanted to extend our previous analyses [11] by
using repeated measurements (baseline, year 11 and year
22) of anxiety and depression symptoms and of blood
pressure within the same community-based population.
The main aim was to study the effect of high level of
combined anxiety and depression on blood pressure
through 22 years; secondly, we wanted to study the indi-
vidual effects of anxiety only and of depression only on
blood pressure; and thirdly, whether alteration in heart
rate could explain these associations.
Methods
Participants
This study is part of the Nord-Trøndelag Health Study
(the HUNT Study, http://www.hunt.no), Norway. All
inhabitants in the county aged ≥20 years were invited to
a general health study that was conducted three times
with 11-year intervals: in 1984-86 (HUNT 1 = baseline)
[18], 1995-97 (HUNT 2 = year 11) [19], and 2006-08
(HUNT 3 = year 22). Data were obtained from physical
examinations, blood samples, and from questionnaires
that covered demographic characteristics, somatic ill-
nesses, somatic and mental symptoms, medication, life
style, and health-related behaviour.
In the present 22-year longitudinal study we included
individuals aged 20-67 years at baseline (HUNT 1) who
participated in all three surveys with valid data on anxi-
ety/depression, blood pressure, heart rate and waist cir-
cumference. Of the 48,907 HUNT 1 participants with
valid data, 5,990 died or moved out of the county during
the first 11 years of follow-up. Among the remaining
42,917 individuals, 34,263 (79.8%) participated with valid
data in HUNT 2. Of these individuals, 4,725 died or
moved out of the county during the next 11 years of fol-
low up. Of the remaining 29,538 individuals, 58.9% par-
ticipated in HUNT-3 with valid data, giving a study
population of 17,410 participants (7888 men, 9522
women) aged 20-67 years at baseline (42-89 years at
year 22). Compared with participants (n = 17,410), those
who did not complete the study (n = 12,128) among eli-
gible individuals at year 22 were older (53 versus 51
years) and were less often women (52.5 versus 54.7%),
had slightly higher mean blood pressure (140.5/82.3 ver-
sus 136.5/81.5 mm Hg) and higher symptom scores of
anxiety (4.33 versus 4.20) and depression (3.76 versus
3.50); p ≤ 0.001 for all comparisons. However, we found
no interaction between age or sex and the association
between anxiety/depression and blood pressure [6,11].
Therefore, we did not expect non-completers to bias
our findings. The personal identification number
allowed linkage of data for each individual. The Norwe-
gian Data Inspectorate and The Regional Committee for
Ethics in Medical Research approved the HUNT study
and the present follow-up study.
Anxiety and depression
Twelve questions on anxiety and depression were
included in the baseline questionnaire, constituting a
one-dimensional anxiety and depression symptom index
(the ADI-12 Index) which was found to correlate
strongly (r = 0.82) with the Hopkins Symptoms Check-
list-25 [11]. The Hospital Anxiety and Depression Scale
(HADS) was employed at year 11 and at year 22. The
HADS is a self-report questionnaire comprising of 14
four-point Likert-scaled items, seven for anxiety
(HADS-A) and seven for depression (HADS-D) [20].
We previously reported that the cross-sectional asso-
ciations between a combined anxiety-depression score
and blood pressure were almost identical at baseline and
at 11-year follow-up, despite use of different measure-
ments of anxiety and depression and of blood pressure
[11]. Cross-sectional analyses at 11-year follow-up also
indicated that HADS-defined anxiety and depression,
respectively, were similarly associated with blood pres-
sure [6]. Consequently, for the 22-year longitudinal ana-
lyses, one-dimensional measures for symptoms of
anxiety and depression were calculated at baseline, 11-
year and 22-year follow-up. Using a categorical
approach, we defined a high symptom level of anxiety/
depression at all three measurements as scores above
the 80
th percentile on the ADI-12 Index at baseline and
as combined HADS-A and HADS-D scores ≥12 (equals
around the 80
th percentiles) at 11-year and at 22-year
follow-up. Finally, we used continuous measures of
anxiety (HADS-A) and of depression (HADS-D), respec-
tively, at 11-year follow-up in analyses of their individual
effects on change in blood pressure from 11-year to 22-
year follow-up. Supplementary analyses were performed
using well-established anxiety/depression cut-offs
(HADS-A ≥ 8, HADS-D ≥ 8) [20].
Blood pressure and heart rate
Specially trained nurses measured blood pressure in
seated participants, after four minutes (baseline) or two
minutes (years 11 and 22), with the cuff placed on the
right upper arm, and with the arm rested on a table at
heart-level. Cuff size was adjusted after measuring the
arm circumference. At baseline, blood pressure was
measured using calibrated mercury manometers with
standard cuff size. The first pulse sound (Korotkoff’s
phase I) was registered as systolic blood pressure and
the level at which the pulse disappeared (phase V) as
diastolic blood pressure. The measurements were
repeated after two minutes, and the second reading was
used in this study. At years 11 and 22, blood pressure
was measured with a Dinamap 845XT (Criticon, Florida,
USA) based on oscillometry. Blood pressure was mea-
sured automatically three times at one-minute intervals.
The mean of the second and third reading was used in
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was counted for 15 seconds or for 30 seconds if the
heart was irregular. At HUNT 2 and 3, heart rate was
measured by the Dinamap. Heart rate was expressed as
beats/min.
Outcome measures
The main outcome measures were change in mean sys-
tolic or diastolic blood pressure (mm Hg) from baseline
to year 22, and from year 11 to year 22. In logistic
regression analyses we used blood pressure ≥ 140/90
mm Hg or < 120/75 mm Hg at year 22 as the outcome
measures.
Statistical analysis
Characteristics of the participants were calculated as
means (± standard deviation) or percentages. We used
linear regression models to analyse the association of
combined anxiety and depression with change in blood
pressure from baseline to year 22. Symptoms of anxiety
and depression were first included as a continuous mea-
sure at baseline, and then categorically as a high symp-
tom level at baseline, at both baseline and year 11, and
at all three measurements, respectively. Effects were
reported as unstandardised regression coefficients (b =
mm Hg change in blood pressure during follow-up). We
repeated analyses after excluding those taking antihyper-
tensive or antidepressant medication, respectively.
We used three regression models. First, we analysed
the association with adjustment for demographic factors
(age, sex, educational level) and systolic or diastolic
blood pressure at baseline. Second, we further adjusted
for angina pectoris, myocardial infarction, stroke, dia-
betes mellitus, smoking status, low physical activity,
antihypertensive medication (baseline and change during
follow-up, all categorical); hypertension among siblings
(baseline and change from baseline to year 11); and
waist circumference (year 11 and change from year 11
to year 22, both continuous). Third, after examining
separately the associations of heart rate with anxiety and
depression and with blood pressure, we included adjust-
ment for heart rate (baseline and change during follow-
up, both continuous) in the analyses of the association
of anxiety and depression with blood pressure.
We also analysed the individual effects of anxiety and
of depression, respectively, at year 11 on change in
blood pressure from year 11 to year 22. In a second
model, we examined the effects of pure anxiety and of
pure depression by adjusting for each other.
In additional logistic regression analyses we examined
the effect of a high symptom level of anxiety/depression
at all three measurements on blood pressure at year 22
dichotomised into hypertension (≥ 140/90 mm Hg) or
not, and then with blood pressure dichotomised into
“hypotension” (< 120/75 mm Hg) [4,10] or not, with
adjustment for age, sex and educational level.
Data were analysed using SPSS version 18.0 for Win-
dows (SPSS Inc, Chicago, Illinois, USA).
Results
Characteristics of the sample are listed in Table 1. An
increase in blood pressure the first 11 years was fol-
lowed by a decrease the next 11 years. Systolic blood
pressure at baseline correlated strongly with that of year
11 (r = 0.61) but more weakly with that of year 22 (r =
0.38). For diastolic blood pressure, the corresponding
figures were r =0 . 5 2a n dr = 0.26. The correlations
between the combined anxiety and depression score at
baseline (the ADI-12 Index)a n dt h eH A D Sa ty e a r s1 1
and 22 were r = 0.45 and r = 0.42, respectively. The cor-
relation between HADS-A at years 11 and 22 was r =
0.59. For HADS-D, the correlation was r =0 . 5 5 .( p<
0.001 for all correlations). There were only minor varia-
tions in the levels of HADS-A and HADS-D scores at
years 11 and 22.
Effect of combined anxiety and depression on mean
blood pressure
We found symptoms of anxiety and depression to pre-
dict a relative decrease in blood pressure during 22-
year follow-up. Baseline level of anxiety and depression
was positively associated with a decrease in systolic
blood pressure in linear regression analyses adjusted
for age, sex, educational level and baseline blood pres-
sure. For diastolic blood pressure, we found a similar
non-significant trend. A high symptom level at both
baseline and at year 11 was more strongly associated
with a decrease in blood pressure during 22-year fol-
low up. In individuals with a high symptom level at all
three examinations, we f o u n da ne v e ns t r o n g e r
decrease for both systolic and diastolic blood pressure
(b = -1.59, p = 0.004, and b = -0.78, p = 0.019, respec-
tively) compared with individuals with a lower symp-
tom level. Additional adjustment for other health
factors and for antihypertensive medication did not
change the overall pattern of results, but the effect of
combined anxiety and depression on blood pressure
was slightly attenuated (Table 2).
Excluding individuals using antidepressant medication
at year 11 (remaining: n = 16,852) did not change the
results essentially: a high symptom level at all three
examinations was associated with a slightly lower
decrease in systolic (b = -1.30, p = 0.023) and diastolic
(b = -0.66, p = 0.047) blood pressure. However, after
excluding those using antihypertensive medication at
baseline or at year 22 (remaining: n = 12,235), we found
a stronger effect on systolic (b = -2.51, p < 0.001) and
diastolic (b = -1.26, p = 0.001) blood pressure.
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blood pressure
In analyses using symptoms of anxiety and depression as
continuous scores separately at year 11, we found that
both anxiety and depression predicted lower blood pres-
sure at year 22. In analyses where anxiety and depres-
sion were further adjusted for each other, the remaining
(pure) effects of anxiety and of depression on blood
pressure were attenuated or became non-significant
(Table 3). Further adjustment for other health factors,
antihypertensive medication and heart rate slightly atte-
nuated the associations, similarly as shown in Table 2.
Supplementary analyses using anxiety/depression cut-
offs (HADS-A ≥ 8, HADS-D ≥ 8) confirmed the direc-
tion and increased the strength of the associations
described above. However, several of the findings
became non-significant (Table 3).
Heart rate
At baseline, an increase in symptoms of combined anxi-
ety and depression (per standard deviation) was asso-
ciated with a dose-response increase in heart rate, as
shown by regression coefficient (b) = 0.36, p < 0.001, in
cross-sectional analyses adjusted for age, sex and educa-
tional level. Prospectively, a high symptom level at all
three examinations was non-significantly associated with
an increased heart rate at year 22 (b = 0.52, p = 0.16)
compared with individuals with a lower symptom level.
Similarly, at baseline, an increase in heart rate was asso-
ciated with an increase in systolic (b = 0.28, p < 0.001)
and diastolic (b = 0.14, p < 0.001) blood pressure. Pro-
spectively, an increase in heart rate from baseline to
year 22 was associated with an increase in systolic (b =
0.16, p < 0.001) and diastolic (b = 0.14, p < 0.001) blood
pressure.
Table 1 Characteristics of participants (n = 17,410) at baseline, at 11-year, and at 22-year follow-up
Baseline
(HUNT 1, 1984-86)
11-year follow-up
(HUNT 2, 1995-97)
22-year follow-up
(HUNT 3, 2006-08)
Demographics
Age, y 40.0 ± 10.6
Sex, % female 54.7
Educational level, %
Low 37.3
Medium 48.6
High 14.0
HADS
1 defined symptom level
Anxiety 4.2 ± 3.2 3.9 ± 3.2
Depression 3.5 ± 2.9 3.6 ± 2.9
Blood pressure, mm Hg
Systolic 126.7 ± 15.9 136.5 ± 19.3 135.1 ± 19.3
Diastolic 80.9 ± 10.5 81.5 ± 11.2 75.2 ± 11.1
Heart rate, bpm 73.0 ± 11.6 71.6 ± 12.2 69.4 ± 11.7
Medical history, %
Angina pectoris 0.7 2.7 5.1
Myocardial infarction 0.3 1.8 4.6
Stroke 0.2 0.8 3.4
Diabetes mellitus 0.5 1.7 5.7
Hypertension among siblings 9.9 11.8 No data
Lifestyle and health factors
Waist circumference, cm No data 86.0 ± 10.9 95.1 ± 11.6
Low physical activity, %
2 39.4 26.1 21.9
Smoking, % 31.0 25.6 17.8
Medication
Antidepressants, % No data 3.2 No data
Antihypertensives, %
3 4.7 11.5 29.0
Data are percentages or means ± standard deviation.
Bpm, beats per minute
1The Hospital Anxiety and Depression Scale (At HUNT 1, a one-dimensional anxiety and depression symptom index was used).
2Defined as physical activity less than once a week (HUNT 1 and 3) or less than one hour a week (HUNT 2).
3Previously or currently.
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analyses of anxiety and depression with change in blood
pressure improved the models, as shown by an increase
in explained variance (adjusted R
2). In all analyses, we
found that additional adjustment for heart rate attenu-
ated the adjusting effect of the other covariates (Table 2).
Effect of combined anxiety and depression on
hypertension or “hypotension”
Logistic regression analyses confirmed the results from
the linear regression analyses. We found that a high
symptom level of combined anxiety/depression at all
three measurements, compared to a lower symptom
level, was associated with reduced odds for blood pres-
sure ≥ 140/90 mm Hg at year 22 (odds ratio 0.80, confi-
dence interval 0.70 - 0.92) and, conversely, with higher
odds for blood pressure < 120/75 mm Hg (odds ratio
1.20, confidence interval 1.05 - 1.36). Thus, the prob-
ability for development of hypertension among indivi-
duals with a high symptom level of anxiety/depression
at all three examinations was 20% lower compared to
those with a lower symptom level.
Table 2 Association of combined anxiety/depression scores
1 with change in blood pressure from baseline (HUNT 1) to
22-year follow-up (HUNT 3)
Adjusted for age, sex, educational
level, and baseline BP
2
Additionally adjusted for health
factors and medication
3
Additionally adjusted for
heart rate
4
B PR
2 B PR
2 B PR
2
Combined anxiety/depression Systolic blood pressure
Baseline, per SD increase -0.39 0.009 0.22 -0.32 0.032 0.23 -0.33 0.025 0.24
High at baseline -0.67 0.044 0.22 -0.55 0.099 0.23 -0.61 0.067 0.24
High at baseline and at 11 y -1.27 0.006 0.22 -1.15 0.012 0.23 -1.21 0.008 0.24
High at baseline, 11 y and 22 y -1.59 0.004 0.22 -1.49 0.007 0.23 -1.51 0.006 0.24
Combined anxiety/depression Diastolic blood pressure
Baseline, per SD increase -0.17 0.054 0.38 -0.12 0.176 0.39 -0.13 0.145 0.42
High at baseline -0.25 0.201 0.38 -0.15 0.439 0.39 -0.21 0.278 0.42
High at baseline and at 11 y -0.54 0.050 0.38 -0.44 0.110 0.39 -0.51 0.058 0.42
High at baseline, 11 y and 22 y -0.78 0.019 0.38 -0.73 0.026 0.39 -0.75 0.019 0.42
BP, blood pressure; SD, standard deviation; B, mm Hg change in BP during follow-up, from linear regression analyses.
1Estimated with the Anxiety and Depression Symptom Index-12 (HUNT 1) and the Hospital Anxiety and Depression Scale (HUNT 2 and 3). A high symptom level
was defined as score above the 80
th percentile of the two scales.
2Systolic or diastolic.
3Angina pectoris, myocardial infarction, stroke, diabetes mellitus, smoking status, low physical activity, antihypertensive medication (baseline and change during
follow-up); hypertension among siblings (baseline and change from baseline to year 11); and waist circumference (year 11 and change from year 11 to year 22).
4Baseline and change during follow-up.
Table 3 Association of anxiety and depression
1 at 11-year follow-up (HUNT 2) with change in blood pressure from 11-
year to 22-year follow-up (HUNT 3)
Adjusted for age, sex, educational level, and BP
2 at
HUNT 2
Additionally adjusted for depression or anxiety,
respectively
BP R
2 BP R
2
Systolic blood pressure
Anxiety, per SD increase -0.41 0.001 0.26 -0.23 0.145 0.26
Anxiety, case level
3 -0.70 0.049 0.26 -0.54 0.159 0.26
Depression, per SD increase -0.46 < 0.001 0.26 -0.31 0.045 0.26
Depression, case level
3 -0.74 0.078 0.26 0.48 0.294 0.26
Diastolic blood pressure
Anxiety, per SD increase -0.21 0.004 0.34 -0.15 0.102 0.34
Anxiety, case level
3 -0.40 0.051 0.34 -0.31 0.161 0.34
Depression, per SD increase -0.20 0.006 0.34 -0.11 0.223 0.34
Depression, case level
3 -0.42 0.085 0.34 -0.27 0.303 0.34
BP, blood pressure; SD, standard deviation; B, mm Hg change in BP during follow-up from linear regression analyses.
1Measured with the Hospital Anxiety and Depression Scale (HADS).
2Systolic or diastolic.
3Case level = score ≥ 8 on HADS-A or HADS-D, respectively.
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Recently, we reported that symptoms of combined anxi-
ety and depression predicted a decrease in blood pres-
sure 11 years later in both sexes and in all adult age
groups [11]. The present study extends our previous
findings by showing that the decrease in blood pressure
was even stronger when a high symptom level was pre-
sent at all three examinations (baseline, year 11 and year
22). We also found that both anxiety and depression
separately contributed to the lowering of blood pressure.
Furthermore, the associations were only slightly attenu-
ated in multivariate analyses, with no evidence of a
mediating effect of alteration in heart rate.
Although one might question the clinical value of a
modest reduction in mean blood pressure, studies have
suggested that this might translate into significant public
health benefits [21]. In our population we found that a
high symptom level of anxiety and depression at all
three examinations reduced the risk of being hyperten-
sive at year 22 by 20%.
The study confirms and extends findings from other
large population-based studies indicating that symptoms
of anxiety and depression predict lower blood pressure
[3-11]. Together, these findings contrast with the
hypothesis that the well established association between
depression and cardiovascular disease might be
explained by elevated blood pressure [22]. In a previous
study, we have discussed conflicting results in other
reports [11]. Recently, four studies with non significant
or contradictory findings were hard to interpret due the
use of self-reported hypertension instead of direct mea-
surement of blood pressure [13-15], significant findings
in middle-aged but not in elderly [13], a short period of
follow-up [16], and a possible mediating role of tricyclic
antidepressants [16].
Our findings also contrast with a recent study based
on data from the British Whitehall II Study suggesting
that the risk of hypertension increased with repeated
experience of depressive symptoms over time [12]. How-
ever, although this study benefited from five waves of
screening data of depressive symptoms and blood pres-
sure, it had some limitations. First, it included only civil
servants aged 35 to 55 years at baseline; thus, it was not
representative of the general population. Second, the
findings were not significant in women. Third, covari-
ates (such as smoking, physical activity, body mass
index and medical conditions) were only assessed at
baseline. These limitations may perhaps explain some of
the inconsistency between this study [12] and our study.
In addition, compared to the HUNT study, the White-
hall study had a much higher proportion (11%) of non-
white participants in which they reported higher odds
for hypertension. Of note, in the present study we also
included anxiety; analysed mental symptoms and blood
pressure both as continuous and as categorical variables;
and adjusted for change in covariates (including heart
rate) during follow-up.
With a few exceptions [12,17], previous studies on this
topic have assessed mental distress only at baseline. We
examined these associations in a large community-based
population using repeated assessments of anxiety,
depression and blood pressure. We found that the effect
of anxiety and depression on blood pressure was more
clearly uncovered with increasing number of assess-
ments, which increase the reliability of measurements as
compared to a single one. Moreover, it seems reasonable
that ongoing symptoms of anxiety and/or depression
have stronger long-term physiological effects than a
shorter period of mental distress. Therefore, the authors
of a previous study emphasized the importance of
repeated assessments when evaluating the effect of men-
tal distress on blood pressure [17]. They reported partly
opposite findings as compared to ours; however, their
study had a small sample size prone to selection bias.
Blood pressure, heart rate, and depression are all
related to cardiovascular mortality, whereas the litera-
ture on anxiety is more conflicting [23]. Regarding
heart rate, a high level seems to be a marker of cardio-
vascular events in general populations [24] and in
patients with established cardiovascular disease [25]. It
is also reported to be associated with depressive symp-
toms [26-29]. We found a weak cross-sectional asso-
ciation of anxiety/depression with an increase in heart
rate. One might speculate whether increased resting
heart rate acts as a mediator of the association
between emotional stress and cardiovascular events,
but this has not been established [27]. Regarding the
third aim of this study, we found, however, no evi-
dence for a mediating effect of heart rate on the asso-
ciation between anxiety/depression and decrease in
blood pressure.
This study provides the first data suggesting that the
pathophysiological mechanisms underlying the observed
association do not involve alteration in heart rate. In
recent years, authors of other epidemiological studies
have proposed various mechanisms, including the use of
antihypertensive medication, but no explanation for the
association has been found [8]. Neither did our results
explain the relationship between anxiety/depression and
blood pressure: First, the association persisted after
excluding individuals using antidepressants or antihyper-
tensive medications, thus leaving out any pharmacologi-
cal explanation. Second, several risk factors usually
associated with blood pressure explained very little of
the association. Previously, we have discussed that neu-
ropeptide Y and related peptides might be involved in
the association between anxiety/depression and decrease
in blood pressure [6,11]. These peptides seem associated
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eral mental symptoms and disorders.
A recent review deals with other possible mechanisms
between chronic psychological states like anxiety and
depression and the cardiovascular system [30]. These
mechanisms involve changes in sympathetic-parasympa-
thetic balance and the tone of the hypothalamic-pitui-
tary-adrenal axis. Previo u sf i n d i n g si n d i c a t e d
hypersecretion of cortisol in patients with major depres-
sion and various dysregulation of cortisol in other forms
of chronic psychological stress, including anxiety and
post-traumatic stress disorder. However, dysregulation
does not always present with high cortisol levels. It may
present with a blunted amplitude of cortisol secretion
and impaired responsiveness to acute stressors [30]. As
we had no data on stress hormone concentrations, the
present study shed no new light on whether dysregula-
tion of cortisol secretion explains part of the association
of chronic elevated symptom levels of anxiety/depres-
sion with decrease in blood pressure.
Limitations of the present study include that different
methods of measuring blood pressure, anxiety and
depression were used at baseline compared to at years
11 and 22. We have previously examined and discussed
this potential limitation [6,11]. However, our cross-sec-
tional and longitudinal findings in the same population
indicated no major problems applying different methods.
Additionally, our present findings based on identical
methods used at years 11 and 22 (Table 3) confirmed
the effect of anxiety and depression on decrease in
blood pressure. This makes it even more unlikely that
different methods of measuring anxiety/depression and
blood pressure could influence the associations we have
observed.
Second, it might be argued that measurement of blood
pressure and mental symptoms at three single time
points gives only snapshots of the participants’ situation
during 22 year of follow-up. However, the procedures at
each wave were standardised and all participants under-
went similar examinations. Moreover, in large epidemio-
logical studies like the HUNT study, screening
instruments are the standard. Certainly there have been
fluctuations in mental symptoms and blood pressure
between the three assessments, but it is unlikely that
this would bias the association in any particular direc-
tion. Statistically, reduced validity of measuring blood
pressure or anxiety/depression would weaken rather
than strengthen any association between them. It is also
of note that the association between a high anxiety/
depression symptom level and decrease in blood pres-
sure from baseline to year 22, and from year 11 to 22,
was similar to the association we previously found from
baseline to year 11 in the same individuals. Given our
large data-set based on standardised procedures, we
regard that our findings indicate a true association
between anxiety/depression and decrease in blood
pressure.
Third, we had data only on resting heart rate but not
on heart rate variability which is a more precise index of
autonomic nervous function than heart rate alone. Low
heart rate variability reflects excessive sympathetic and/
or inadequate parasympathetic modulation of heart rate
and is found associated with depression [26] and anxiety
[31] both in general populations [27-29] and in patients
with coronary heart disease [26,32]. These findings may
explain some of the cardiovascular risk associated with
depression [26]. Additionally, a large population-based
study has reported that low heart rate variability was
associated with the development of hypertension [33]. It
follows that adjustment for heart rate variability in ana-
lyses of the association between anxiety/depression and
blood pressure would be of interest.
Conclusions
This study benefits from being a large general popula-
tion-based study covering a wide age range, using
repeated assessments of anxiety, depression and blood
pressure over 22 years. We found that anxiety and
depression were associated with decrease in blood pres-
sure, particularly in individuals with a persistent high
symptom level. Heart rate did not mediate the associa-
tion. The significance of our findings lies partially in sti-
mulating further research on the underlying biological
pathways between mental symptoms and blood pressure
regulation. Our findings should also have consequences
for clinical studies on pharmacological treatment of
blood pressure which should take common mental
symptoms of participants into account.
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